CLOROX CO /DE/ CLX

Clorox's current evidence rail is led by official SEC EDGAR activity, including a 2026-06-17 8-K carrying a press release, a 2026-06-01 SD filing, a 2026-05-28 8-K carrying another press release, a 2026-05-11 8-K, a 2026-05-08 424B2 and a 2026-05-06 FWP. The named developments matter because this is not a rumour file or an analyst-note wrapper. It is a filing-led daily read on CLOROX CO /DE/.

The company itself is defined in the supplied 424B2 as a leading multinational manufacturer and marketer of consumer and professional products, with approximately 7,600 employees worldwide as of 2026-03-31. The same filing says it markets industry-leading products and technologies for professional customers under brands including CloroxPro and Clorox Healthcare. That product rail keeps the equity story attached to real customers, cleaning categories and professional channels rather than floating away into ticker prose.

The latest supplied SEC EDGAR financial facts show revenue from contracts with customers of $1.67B, net income attributable to the parent of $187.0M and diluted EPS of $1.54 for the 10-Q period ended 2026-03-31. The same 10-Q rail shows assets of $6.44B, liabilities of $6.34B, stockholders' equity attributable to the parent of $-67.0M, cash and cash equivalents of $1.19B, net cash provided by operating activities of $282.0M, property, plant and equipment payments of $121.0M, research and development expense of $27.0M, inventory of $588.0M and an increase in inventories of $64.0M.

No chart route or TradingView source is supplied in this evidence pack, so this report does not claim candle levels, moving averages, support, resistance or price action. The useful market mechanism here is simpler and more accountable: a consumer and professional products issuer with recent SEC filings, positive latest-period net income and operating cash flow, a meaningful cash balance, inventory movement, capital spending and a negative stockholders' equity line.

The 2026-06-01 SD filing adds a source trail rather than an earnings number: it points to an exhibit available at www.thecloroxcompany.com/conflictmineralsreport. That matters as a supply-chain disclosure marker, while the supplied extract does not establish product-level sourcing outcomes, customer reaction or financial impact. The 2026-06-17 and 2026-05-28 8-Ks also include official press-release evidence and image candidates, but the rail does not supply the full release text inside this brief, so the report can name the filings without inventing the announcements.

What remains unproven is as important as what is filed. The pack does not supply guidance, segment revenue, gross margin, dividend detail, buyback data, share-price movement, management commentary or a parsed chart view. The file is therefore strongest on official identity, recent filing activity, latest available 10-Q facts and product-channel context, and deliberately quiet on anything the rail does not prove.